| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11022086 | Chronic Diseases and Translational Medicine | 2018 | 8 Pages |
Abstract
Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality worldwide. Treatment options for patients with advanced stage HCC remain a great challenge. However, novel agents especially small molecule tyrosine kinase inhibitor and innovative immunotherapy demonstrate new promising therapeutic options for these patients. This review article summarizes systemic treatment options evaluated in HCC focusing on the most recently published data and ongoing studies.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Manushi Aggarwal, Abeer Arain, Zhaohui Jin,